Point-of-care testing during medical emergency team activations: A pilot study

被引:8
作者
Calzavaccaa, P. [1 ,2 ]
Licari, E. [1 ,2 ]
Tee, A. [1 ,2 ]
Bellomo, R. [1 ,2 ]
机构
[1] Austin Hosp, Dept Intens Care, Melbourne, Vic 3084, Australia
[2] Austin Hosp, Dept Med, Melbourne, Vic 3084, Australia
关键词
Medical emergency team; Rapid response system; Critical illness; D dimer; Brain natriuretic peptide; Myoglobin; Creatinine kinase; Troponin I; Mortality; CRITICALLY-ILL PATIENTS; DISSEMINATED INTRAVASCULAR COAGULATION; INTENSIVE-CARE; NATRIURETIC PEPTIDE; D-DIMER; HEART-FAILURE; PULMONARY-DISEASE; VENOUS THROMBOEMBOLISM; MYOCARDIAL-INFARCTION; CONSENSUS CONFERENCE;
D O I
10.1016/j.resuscitation.2012.02.012
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To estimate the prognostic value of point-of-care measurement of biomarkers related to dyspnea in patients receiving a medical emergency team (MET) review. Design: Prospective observational study. Setting: University affiliated hospital. Patients: Cohort of 95 patients receiving MET review over a six month period. Methods: We used a commercial multi-biomarker panel for shortness-of-breath (SOB panel) (Biosite Triage Profiler, Biosite Incorporated (R), 9975 Summers Ridge Road, San Diego, CA 92121, USA) including Brain natriuretic peptide (BNP), D-dimer, myoglobin (Myo), creatine kinase MB isoenzyme (CK-MB) and troponin I (Tn-I). We recorded information about demographics, MET review triggers, and MET procedures and patient outcome. Results: Mean age was 70.5 (+/- 15) years, 38 (41%) patients had a history of chronic heart failure (CHF) and 67 (70%) chronic kidney disease (CKD). At MET activation, 42 (44%) patients were dyspneic. The multi-biomarker panel was positive for at least one marker in 48 (51%) cases. BNP and D-dimer had a sensitivity of 0.79 and 0.93 for ICU admission with a negative predictive value (NPV) of 0.89 and 0.92 respectively. Thirty-five (37%) patients died. BNP was positive in 85% of such cases with sensitivity and NPV of 0.86 and 0.82, respectively. D-dimer was positive in 77% of non-survivors with a sensitivity and NPV of 0.94 and 0.88, respectively. BNP (area under the curve of receiver operating characteristic curve -AUC-ROC: 0.638) and D-dimer (AUC-ROC: 0.574) achieved poor discrimination of subsequent death. Similar findings applied to ICU admission. The combination of normal BNP and D-dimer levels completely ruled out ICU admission or death. The cardiac part of the panel was not useful in predicting ICU admission or mortality. Conclusions: Although, BNP and D-dimer are poor discriminants of ICU admission and hospital mortality, normal BNP and D-dimer levels practically exclude subsequent need for ICU admission and hospital mortality. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1119 / 1123
页数:5
相关论文
共 50 条
  • [31] Place of Point-of-Care Ultrasound in Emergency Medicine
    Bobbia, X.
    Claret, P-G
    Perrin-Bayard, R.
    de La Coussaye, J-E
    ANNALES FRANCAISES DE MEDECINE D URGENCE, 2020, 10 (01): : 31 - 37
  • [32] EARLY POINT-OF-CARE TESTING AT TRIAGE REDUCES CARE TIME IN STABLE ADULT EMERGENCY DEPARTMENT PATIENTS
    Singer, Adam J.
    Taylor, Merry
    LeBlanc, Deborah
    Meyers, Kristen
    Perez, Karol
    Thode, Henry C., Jr.
    Pines, Jesse M.
    JOURNAL OF EMERGENCY MEDICINE, 2018, 55 (02) : 172 - 178
  • [33] Point-of-Care Testing for D-Dimer in the Diagnosis of Venous Thromboembolism in Primary Care: A Narrative Review
    Price, Christopher P.
    Fay, Matthew
    Hopstaken, Rogier M.
    CARDIOLOGY AND THERAPY, 2021, 10 (01) : 27 - 40
  • [34] Point-of-Care Testing for D-Dimer in the Diagnosis of Venous Thromboembolism in Primary Care: A Narrative Review
    Christopher P. Price
    Matthew Fay
    Rogier M. Hopstaken
    Cardiology and Therapy, 2021, 10 : 27 - 40
  • [35] Point-of-Care Testing in the Diagnosis of Deep Vein Thrombosis: A Review
    Zhang, Zejun
    Wu, Junding
    Cheng, Wanjun
    Zhang, Xia
    Xu, Lisheng
    Yao, Yudong
    IEEE SYSTEMS MAN AND CYBERNETICS MAGAZINE, 2023, 9 (02): : 49 - 56
  • [36] Cardiac Troponin by Point-of-Care Testing The Once and Future King?
    Collinson, Paul
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (10) : 1125 - 1127
  • [37] Point-of-care testing for D-dimer in the exclusion of venous thromboembolism: a critical analysis
    Grand, Francois
    Blanc-Jouvan, Florence
    Delassasseigne, Celine
    Galinat, Hubert
    Roy, Pierre-Marie
    Talon, Laurie
    Toussaint-Hacquard, Marie
    Macchi, Laurent
    ANNALES DE BIOLOGIE CLINIQUE, 2023, 81 (05) : 461 - 474
  • [38] Point-of-care lung ultrasound in paediatric critical and emergency care
    Dominguez, Anna
    Gaspar, Heloisa A.
    Preto, Marcela
    Ejzenberg, Fernanda E.
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2018, 54 (09) : 945 - 952
  • [39] Point-of-care platelet function testing to predict blood loss after coronary artery bypass grafting surgery: a prospective observational pilot study
    Ellis, James
    Valencia, Oswaldo
    Crerar-Gilbert, Agnieszka
    Phillips, Simon
    Meeran, Hanif
    Sharma, Vivek
    PERFUSION-UK, 2016, 31 (08): : 676 - 682
  • [40] Cardiac biomarkers and the case for point-of-care testing
    McDonnell, Barry
    Hearty, Stephen
    Leonard, Paul
    O'Kennedy, Richard
    CLINICAL BIOCHEMISTRY, 2009, 42 (7-8) : 549 - 561